Bacteriology Culture/Sensitivities
The Bacteriology Culture/Sensitivities test identifies pathogenic enteric bacteria—Salmonella, Shigella, Campylobacter, pathogenic E. coli, Yersinia, Vibrio, Aeromonas—in stool and determines their antimicrobial susceptibility. It is the definitive diagnostic for bacterial gastroenteritis, guides targeted therapy, and supports public health surveillance and outbreak investigation.
2
Biomarkers
Stool
Sample
3–7 business days
Turnaround
No
Fasting
What is the Bacteriology Culture test?
The Bacteriology Culture/Sensitivities test identifies pathogenic bacteria in stool and determines their antimicrobial susceptibility profile. It is the definitive diagnostic method for bacterial gastroenteritis caused by recognised enteric pathogens, enabling species-level identification and guiding targeted antimicrobial therapy when treatment is indicated. Bacterial culture is ordered when the clinical picture — acute diarrhoea, fever, mucoid or bloody stools, recent travel, or foodborne exposure — suggests a bacterial aetiology. Because most acute diarrhoea is self-limited and viral or toxin-mediated, culture is reserved for patients with severe symptoms, immunocompromise, healthcare or outbreak settings, or when antimicrobial therapy is being considered. The test also serves a public health function: confirmed isolates of Salmonella, Shigella, and other notifiable pathogens trigger case investigation and contact tracing.
What does the Bacteriology Culture test measure?
The gastrointestinal tract harbours a complex microbial ecosystem in which commensal organisms outnumber pathogens many-fold. Traditional stool culture employs selective and differential media to isolate known enteric bacterial pathogens — Salmonella, Shigella, Campylobacter, pathogenic Escherichia coli (including enterohaemorrhagic, enterotoxigenic, and enteroinvasive pathotypes), Yersinia enterocolitica, Vibrio, and Aeromonas species — that are not part of the normal flora. Recovery depends on organism load, transport time, and prior antimicrobial exposure.
Detection of a pathogenic isolate confirms bacterial gastroenteritis, informs antimicrobial choice, and enables public health reporting. Negative culture does not exclude bacterial infection if the organism is fastidious, the specimen was delayed, or antimicrobials were started before collection. Culture sensitivities guide therapy when resistance is suspected and help tailor treatment in severe or persistent disease.
Susceptibility testing measures the in-vitro activity of antimicrobials against a recovered isolate, typically by disc diffusion or automated broth microdilution. Results are interpreted against breakpoints that predict clinical response and correlate with the pharmacodynamics of each drug and infection site. Testing panels are chosen according to the organism identified and local resistance epidemiology.
Susceptibility data allow practitioners to select an effective agent, de-escalate empirical broad-spectrum therapy, and avoid drugs likely to fail. For public health surveillance, resistance patterns inform empirical guidelines and track the emergence of multidrug-resistant strains.
Why is the Bacteriology Culture test ordered?
- Investigation of acute bloody diarrhoea (dysentery) where bacterial pathogens such as Shigella, Campylobacter, or enterohaemorrhagic E. coli are suspected
- Evaluation of persistent diarrhoea (>7 days) that has not responded to empirical therapy or when a bacterial cause is considered
- Work-up of diarrhoea in immunocompromised patients (HIV, transplant recipients, chemotherapy), where bacterial pathogens may cause severe disease
- Assessment of travellers returning with acute diarrhoea and fever, particularly from regions endemic for Salmonella, Shigella, Campylobacter, or enterotoxigenic E. coli
- Outbreak investigation in healthcare facilities, food service, or community settings where bacterial foodborne or waterborne transmission is suspected
- Pre-treatment culture and susceptibility testing when antimicrobials are being considered for severe or systemic bacterial gastroenteritis, guiding agent selection and duration
- Public health surveillance and notifiable disease reporting for confirmed isolates of Salmonella, Shigella, and other regulated pathogens
- Evaluation of healthcare-associated diarrhoea not attributable to Clostridioides difficile, where hospital-acquired bacterial pathogens may be present
Sample collection and turnaround
Sample type
Stool
Fasting required
No
Collection method
At-home collection kit
Turnaround
3–7 business days
Collection notes
Patient collects a fresh stool specimen into the provided sterile container with transport medium (typically Cary-Blair), avoiding contamination with urine, water, or toilet chemicals. Specimen should be collected during acute diarrhoea and ideally before antimicrobial therapy is started. Ship to Doctor's Data according to kit instructions; refrigerate if shipping is delayed beyond a few hours.
Specimen requirements
Approximately 1–2 grams of stool (pea-sized) in Cary-Blair or equivalent transport medium. Avoid preservatives or fixatives intended for parasite testing, which inhibit bacterial growth. Note recent antimicrobial use and travel history on the requisition to guide laboratory interpretation.
What can affect Bacteriology Culture results?
Even short courses of antimicrobials can suppress bacterial growth and yield false-negative cultures; ideally collect the specimen before starting therapy or note recent exposure for interpretation.
Enteric pathogens, particularly Shigella and Campylobacter, are labile; specimens should reach the laboratory within hours or be placed in Cary-Blair or other transport medium to preserve viability.
Pathogen shedding peaks during acute illness; specimens collected late in the course or after diarrhoea has resolved may miss the organism.
Heavy overgrowth of commensal organisms can obscure pathogens on culture plates; selective media mitigate this, but fastidious pathogens may still be missed.
Residues of antiseptics, toilet cleaners, or urine in the container can inhibit bacterial growth; use a clean, dedicated collection vessel.
Culture sensitivity depends on organism density; low-level carriage or certain pathotypes (for example some enterotoxigenic E. coli) may not grow on standard media.
What do Bacteriology Culture results mean?
Elevated
Not applicable — bacteriology culture is qualitative. A positive result reports the identity of the pathogenic isolate (for example Salmonella enterica serovar, Campylobacter jejuni, Shigella species, or pathogenic E. coli) and its susceptibility pattern, confirming bacterial gastroenteritis and guiding antimicrobial selection when therapy is warranted.
Normal
No growth of Salmonella, Shigella, Campylobacter, Yersinia, pathogenic E. coli, Vibrio, or Aeromonas on the culture media tested. A negative culture does not exclude bacterial infection if the organism is fastidious, the specimen was delayed or collected after antimicrobials were started, or the pathogen is not targeted by the laboratory's standard panel.
Reduced
Not applicable — the relevant finding is presence or absence of a pathogen.
Note: Culture detects only the pathogens for which selective media are used; emerging or uncommon organisms may be missed. Susceptibility results are in-vitro predictions and must be interpreted with the infection site, severity, and pharmacokinetics of each agent. Many episodes of bacterial gastroenteritis are self-limited and do not require antimicrobials; treatment is reserved for severe, invasive, or high-risk cases. Positive cultures of notifiable organisms must be reported to public health authorities.
Frequently asked questions
A stool bacteriology culture targets recognised enteric pathogens: Salmonella, Shigella, Campylobacter, pathogenic Escherichia coli (including enterohaemorrhagic and enterotoxigenic strains), Yersinia enterocolitica, Vibrio, and Aeromonas species. It does not detect viruses, parasites, or Clostridioides difficile, which require separate tests.
How to access the Bacteriology Culture test
The Bacteriology Culture reference page is free and open to all practitioners. Create a free practitioner account to see pricing, save tests to your list, and generate requisition forms. Verification takes 1–2 business days.
Create Free AccountAbout this page
Published: October 7, 2026
Last reviewed: October 7, 2026
- Shane AL, et al. Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. (2017)
- Riddle MS, et al. ACG clinical guideline: diagnosis, treatment, and prevention of acute diarrheal infections in adults. Am J Gastroenterol. (2016)
- CLSI. Performance standards for antimicrobial susceptibility testing (M100). (2023)
- EUCAST. Breakpoint tables for interpretation of MICs and zone diameters. (2023)
- Scallan E, et al. Foodborne illness acquired in the United States — major pathogens. Emerg Infect Dis. (2011)
This content is for licensed healthcare practitioners only and does not constitute medical advice. Clinical decisions should be based on the full clinical picture and not on any single test result.